Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies

Area of Science:

• Neurology
• Genetics
• Pathology

Background:

• Dystrophinopathy is a genetic skeletal muscle disease caused by insufficient dystrophin.
• Traditional diagnosis relies on muscle pathology and immunohistochemistry, but biopsies are declining.
• Advances in genetic therapies necessitate evolving diagnostic approaches.

Purpose of the Study:

• To review current diagnostic practices for dystrophinopathy using muscle biopsies.
• To explore the evolution of these practices in light of new genetic therapies.
• To highlight the importance of evaluating dystrophin expression in research settings.

Main Methods:

• Review of current literature on dystrophinopathy diagnosis.
• Analysis of traditional pathological and immunohistochemical methods.
• Discussion of diagnostic adaptations for emerging genetic therapies like exon skipping and gene therapy.

Main Results:

• Muscle biopsies for dystrophinopathy diagnosis are becoming less common.
• The evaluation of dystrophin expression is increasingly critical for research and therapeutic development.
• Existing diagnostic methods require adaptation to meet the needs of new genetic interventions.

Conclusions:

• Diagnostic practices for dystrophinopathy must evolve beyond traditional muscle biopsies.
• New methods for evaluating dystrophin expression are crucial for advancing genetic therapies.
• The field is shifting towards research-based evaluations to support therapeutic interventions.